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Case report
Synovial sarcoma of the parotid gland:
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Sarcoma sinoviale della ghiandola parotide: case report e revisione della letteratura
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SummAry
Parotid gland tumours are very heterogeneous, being benign in 80% of cases, and generally arising from epithelial cells. nevertheless, 
a small group of non-epithelial tumours representing just 5% of all salivary gland neoplasms has also been reported, the most common 
of these being haemangioma, especially in children. however, lymphomas, neuromas, neurofibromas, lipomas and sarcomas can also be 
found. Synovial cell sarcoma is a high grade histological variety of sarcoma and is generally located near large joints and bursae of the 
lower extremities, such as knee, tendon sheaths and bursal structures. it is rarely found in the head and neck region due to its lack of syn-
ovioblastic tissue. herewith, the case of a young female, affected by a synovial sarcoma of the left parotid gland, is presented and a review 
is made of the literature on this rare specific localization focusing on management and outcome.
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riASSunTo
I tumori delle ghiandole parotidi sono molto eterogenei, benigni nell’80% dei casi, e in genere derivanti da cellule epiteliali. Esiste anche 
un piccolo gruppo di tumori non-epiteliali che rappresentano appena il 5% di tutte le neoplasie delle ghiandole salivari. Il più rappre-
sentato di questi è l’emangioma, specialmente nei bambini. Tuttavia si possono anche trovare linfomi, neurinomi, neurofibromi, lipomi e 
sarcomi. Il sarcoma sinoviale è una varietà di sarcoma ad alto grado istopatologico e generalmente si localizza nei pressi delle grandi 
articolazioni e borse delle estremità inferiori, come il ginocchio e guaine tendinee. Raramente tale entità si localizza nella regione testa-
collo, poiché essa è povera di tessuto sinovioblastico. Segnaliamo un caso di una giovane donna colpita da un sarcoma sinoviale della 
ghiandola parotide sinistra e riportiamo la revisione della letteratura su questa rara e specifica localizzazione analizzando in particolar 
modo management e outcome.
PArole ChiAve: Sarcomi testa-collo • Tumori della ghiandola parotide • Chirurgia della ghiandola parotide • Sarcoma sinoviale
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Introduction
Sarcomas are malignant soft tissue tumours representing 
only 1% of all malignant tumours and 1% of all head and 
neck malignancies 1. Synovial cell sarcoma (SS) is a high 
grade histological variety of sarcoma and it is the fourth 
most common entity after malignant fibrous histiocyto-
mas, liposarcomas and rhabdomyosarcomas. it typically 
occurs in young adults with a male/female ratio of 2:1 2 3. 
it is located predominantly near large joints and bursae 
of the lower extremities such as knee, tendon sheaths and 
bursal structures, but is rarely found in the head and neck 
(representing only 3% to 10% of synovial cell sarcomas 
and quite often the correlation with synovial structures 
remains  unclear),  because  this  region  is  poor  in  syn-
ovioblastic tissue 4. however, the most common sites of 
localization, in the head and neck region, are hypophar-
ynx and parapharyngeal spaces. in fact, it is possible to 
find the majority of SSs in the paravertebral connective 
tissue spaces, while they are less common in the larynx 5. 
histological diagnosis is generally a late post-operative 
finding 6. due to the rarity of this entity, few cases have 
been described in the literature and treatment is still not 
well codified.
Case report
A 31-year-old female had an 8-month history of a pro-
gressive swelling in the left parotid region. Physical ex-
amination revealed a firm mass 3 x 2 cm, associated with 
local facial pain and ipsilateral otalgia. ultrasound exami-
nation revealed an enlarged left parotid gland, occupied, 
in the middle-upper region of its deep lobe, by a mod-
erately expansive process measuring 31 x 21 mm with a 
solid anechogenic structure, suggesting a warthin tumour. 
magnetic resonance imaging (mri) confirmed a high vol-
ume left parotid mass, with a normal gland profile, with-
out involvement of adjacent vascular structures, bones or 
adipose tissue. regional lymph nodes were not enlarged m. rigante et al.
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Fig. 1. Pre-operative MRI FSE DP/T2 weighted with contrast in axial plane 
(A) and FLAIR TRS in coronal plane (B) showing a left parotid mass close to 
the mandibular ramus and the temporo-mandibular joint.
Fig. 2. A) Fascicles and tiny vortex-shaped formations of spindle-shaped cells with pale nuclei arranged in a myxoid stroma (haematoxylin-eosin stain, mag-
nification x 100); B) Cells with ovoid pale nuclei arranged around slender vascular spaces producing a haemangiopericytoma-like pattern (haematoxylin-eosin 
stain, magnification x 400).
(Fig. 1). Fine-needle aspiration biopsy (FnAB) revealed 
normal acinar cells with oncocytic metaplasia. The patient 
denied any history of trauma or facial surgery.
Total parotidectomy with facial nerve preservation was 
then carried out and was followed by a regular post-oper-
ative course. histology revealed an unencapsulated, lobu-
lated, whitish solid mass composed of cellular fascicles 
and sheets of uniform, small, ovoid cells with plump and 
spindle-shaped pale nuclei, small nucleoli and inconspic-
uous cytoplasm. loosely arranged fascicles in a myxoid 
stroma and collagenized areas were observed. vasculature 
was  prominent  producing  a  haemangiopericytoma-like 
pattern in most areas. immuno-histochemistry revealed 
tumour cell positivity for vimentine, Cd99, Bcl-2 and fo-
cally for epithelial membrane antigen (emA), whereas 
no reactivity for Cd34, CAm5.2, Kl1, Ae1/Ae3, CK14, 
S100, gFAP, p63, Cd117, hhF35, ASmA was detected 
(Figs. 2, 3). Cytogenetic tests showed the characteristic 
(x:18),  SyT/SSX1  translocation.  morphologic,  immu-
nophenotypic  and  molecular  findings  were  compatible 
with primary monophasic synovial sarcoma. Therefore, 
the patient underwent ipsilateral selective neck dissection 
(negative for metastasis) and adjuvant radiotherapy (total 
dose 50 gy). She is free of disease at 3-year follow-up.
Discussion
Salivary gland tumours are mainly located in the parotid 
(80%) and in the submandibular glands (10-15%) while 
sublingual  and  ancillary  glands  are  less  frequently  in-
volved (5-10%) 7. About 80% of parotid gland neoplasms 
are  benign  and  more  than  95%  occur  in  adults. Their 
histopathological  aspects  are  heterogeneous.  The  most 
common parotid gland tumour is pleomorphic adenoma 
(60%) followed by warthin adenoma (5-15%). As far as 
concerns malignant neoplasms the largest percentage is 
represented by mucoepidermoid carcinoma (8-15%) fol-
lowed by adenoid cystic carcinoma (5%). Finally, there is 
a small group of non-epithelial tumours representing just 
5% of all salivary gland neoplasms and generally they are 
benign. The most represented of these is haemangioma, 
especially in children. however we can also find lympho-
ma, neuromas, neurofibromas, lipomas and sarcomas.
Synovial sarcoma (SS) is the fourth most common va-
riety of sarcoma after malignant fibrous histiocytoma, 
liposarcoma and rhabdomyosarcoma 8 9. Two subtypes of 
SS are described in the literature: monophasic and bi-
phasic. The latter contains spindle and epithelioid cells, 
while the former contains only spindle cells. As far as 
concerns SS, 99% present an identifiable translocation 
between chromosome 18 and X that results in the fu-
sion of the SyT genes located on chromosome 18 and 
the SSX-1 or SSX-2 gene on chromosome X. Finding 
this translocation is very important to confirm the histo-
logical diagnosis of SS, especially for the monophasic 
type allowing differential diagnosis with other spindle Synovial sarcoma of parotid gland
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Fig. 3. Neoplastic cells show focal immune-reactivity for the epithelial membrane antigen (EMA) (A) and strong expression of vimentine (B).
cell tumours, such as haemangiopericytoma, neurogen-
ic sarcoma, fibroscarcoma and leiomyosarcoma. Some 
Authors indicated biphasic tumours as more aggressive 
than the monophasic 10 type, whereas another study was 
not in agreement with this difference and, indeed, found 
no differences between the mentioned subtypes 11. The 
American Joint Committee on Cancer has classified all 
synovial sarcomas as high grade malignancies, irrespec-
tive of their phenotypes 12.
A systematic review of the literature, selective for SS aris-
ing from the parotid gland, has shown controversial opin-
ions among the reported cases.
Sex, age at onset, histopathological pattern, size, prognosis 
and  treatment  were  then  evaluated.  Parotid  gland  SS  oc-
curs primarily in males with a high-prevalence rate in young 
adults (> 90% of cases presenting before 50 years of age) 13.
The biphasic type would appear to be more common than 
the monophasic type and generally more aggressive 13-16.
Tumour size has been reported to be highly variable (from 
0.6 mm to 7 cm) 17 and appears to be correlated with prog-
nosis as generally occurs in the other localizations of SS 
(tumours larger than 5 cm 11 18).
Although several reports have suggested an aggressive 
course for head and neck synovial sarcoma 19 20, our case 
and the review of parotid localizations suggest a relatively 
good prognosis, probably due to the easy exploration and 
early recognition of every parotid swellings 14-16 21.
A review of the literature showed an overall disease-free 
survival at 10 and 15 years ranging from approximately 
45% to 50% 22. This rate has improved since 1977 with a 
40% 5-year survival reported in 1977, a 55% 5-year sur-
vival rate in 1982, a 56% 5-year survival rate in 1992 and 
a 60% 5-year survival rate in 1996 14. long-term follow-
up is necessary because of the high incidence of distant 
metastases especially to the lungs (main cause of death in 
approximately 50% of the patients).
An analysis of 36 cases of SS involving the head revealed 
a high prevalence of parotid localizations (14/36) suggest-
ing that this region is the most affected in the head and 
neck area 17.
There are different theories regarding the aetiopatho-
genesis of SS. This tumour sometimes occurs in sites 
not related to the synovium such as parapharyngeal, 
retropharyngeal  or  hypopharyngeal  regions,  tongue, 
cheek or buccal pad, therefore, the histogenesis re-
mains controversial 22. According to leader et al. 23, 
it is currently accepted that SS arises from undiffer-
entiated or pluripotent mesenchymal cells with dual 
differentiation capacity, both epithelial and mesenchy-
mal. This is why this Author suggests classifying SS as 
carcinosarcoma. This theory is in contrast with others 
describing a clear link with joints as beginning sites of 
these sarcomas.
Can  we  confirm  the  role  of  temporomandibular  joints   
(TmJ) in the development of SS located in the parotid 
gland? The absence of SS arising in the other major sali-
vary glands could be related to their distance from any 
facial joints.
The optimal treatment of these tumours seems to be mul-
timodal.  radical  surgery  represents  the  first  approach. 
Post-operative radiation treatment has been found to im-
prove the prognosis in head and neck localizations rather 
than in the extremities 23-25.
Chemotherapy with ifosfamide has been investigated es-
pecially in the hypopharynx and larynx where complete 
excision is sometimes not possible 5 26.
recently, some Authors suggested the possible role of 
epidermal  growth  factor  receptor  (egFr)  and  human 
epithelial growth factor receptor 2 (her-2/neu) in the can-
cerogenesis of SS 27 28 thus suggesting that the anti-egFr 
monoclonal antibody may play a role in the therapeutic 
approach.m. rigante et al.
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Conclusions
Since synovial sarcoma of the parotid gland represents a 
rare entity, the diagnosis and clinical management can be 
a challenge. on account of the loco-regional and systemic 
spread, a multimodality therapeutic approach, as well as 
long-term follow-up are mandatory. The volume of the 
disease seems to be the only clear prognostic factor, such 
as the histological pattern. Parotid gland localizations of 
SS seem to be less aggressive, having a better prognosis 
compared with the other head and neck localizations.
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